Posterior vitreous detachment and macular microvasculature in the elderly.
Aged
Cross-Sectional Studies
Eye
/ diagnostic imaging
Female
Fluorescein Angiography
Humans
Macula Lutea
/ blood supply
Macular Degeneration
/ diagnosis
Male
Microvessels
/ diagnostic imaging
Middle Aged
Retina
/ physiology
Severity of Illness Index
Tomography, Optical Coherence
Vitreous Detachment
/ diagnosis
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
21
02
2020
accepted:
20
03
2020
entrez:
9
4
2020
pubmed:
9
4
2020
medline:
11
7
2020
Statut:
epublish
Résumé
To investigate the association between different stages of posterior vitreous detachment (PVD) and macular microvasculature in the elderly. Swept-source optical coherence tomography (OCT), OCT angiography, and color fundus images of 490 eyes without retinal pathologies of 322 participants aged ≥65 years were evaluated. PVD was classified using enhanced vitreous visualization mode as no apparent PVD (stage 0/1), vitreous adhesions at the fovea and optic disc (stage 2), adhesion at the optic disc (stage 3), or complete PVD (stage 4). Microvascular parameters, including foveal avascular zone (FAZ) and vessel density (VD), were analyzed for their associations with complete PVD. Additionally, the association between PVD and central retinal thickness (CRT) was also addressed. Overall, 80, 31, 31, and 349 eyes were categorized into stages 0/1, 2, 3, and 4, respectively. Using multivariate mixed-effects model, the mean superficial FAZ area was smaller in stage 4 compared with stages 0-3 (0.29 vs. 0.32 mm2; P = 0.014), and the mean superficial VD was lower in stage 4 compared with stages 0-3 (34.96% vs. 35.24%; P = 0.0089). However, PVD was not significantly associated with deep macular microvascular parameters or CRT. Complete PVD was associated with smaller FAZ area and lower VD in superficial macular microvasculature, while it was not associated with central retinal thickness.
Identifiants
pubmed: 32267887
doi: 10.1371/journal.pone.0231351
pii: PONE-D-20-05057
pmc: PMC7141617
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0231351Déclaration de conflit d'intérêts
Topcon (www.topcon.co.jp), supported our condut of the present research, which does not alter our adherence to PLOS ONE policies on sharing data and materials.
Références
Ophthalmology. 2016 Nov;123(11):2352-2367
pubmed: 27523615
Am J Ophthalmol. 2019 Jul;203:103-115
pubmed: 30689991
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT224-34
pubmed: 27409476
Antioxid Redox Signal. 2013 Nov 10;19(14):1690-710
pubmed: 23311950
Sci Rep. 2019 Jan 17;9(1):156
pubmed: 30655557
Ophthalmology. 2019 Dec;126(12):1675-1684
pubmed: 31358386
Ophthalmology. 2013 Dec;120(12):2611-2619
pubmed: 24053995
Surv Ophthalmol. 2016 Mar-Apr;61(2):211-27
pubmed: 26679984
Prog Retin Eye Res. 2017 Sep;60:66-100
pubmed: 28760677
Retina. 2015 Nov;35(11):2188-95
pubmed: 26469536
Ophthalmol Retina. 2018 May;2(5):418-427
pubmed: 30820483
PLoS One. 2017 Nov 27;12(11):e0188572
pubmed: 29176837
Retina. 2007 Oct;27(8):1090-6
pubmed: 18040251
Invest Ophthalmol Vis Sci. 2015 May;56(5):3212-7
pubmed: 26024105
Am J Ophthalmol. 2012 Mar;153(3):497-503
pubmed: 22071231
Sci Rep. 2017 Aug 29;7(1):9853
pubmed: 28851930
Eye (Lond). 2008 Oct;22(10):1273-7
pubmed: 18292784
Invest Ophthalmol Vis Sci. 2019 Mar 1;60(4):990-998
pubmed: 30884528
Ophthalmology. 2018 Sep;125(9):1372-1383
pubmed: 29631900
Transl Vis Sci Technol. 2017 Jun 9;6(3):16
pubmed: 28616362
Ophthalmology. 2018 Feb;125(2):255-266
pubmed: 28964581
Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5780-5787
pubmed: 27792812
Geriatr Gerontol Int. 2018 Apr;18(4):623-630
pubmed: 29278297
Ophthalmology. 2013 Dec;120(12):2620-2629
pubmed: 23870300
Ophthalmology. 1986 Sep;93(9):1188-92
pubmed: 2433663
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT211-23
pubmed: 27409475
Curr Eye Res. 2019 Sep;44(9):980-986
pubmed: 30995128
Ophthalmol Retina. 2018 Sep;2(9):972-978
pubmed: 31047230
Aging Clin Exp Res. 2018 Apr;30(4):331-340
pubmed: 28560545
Am J Ophthalmol. 2009 Jun;147(6):1012-6
pubmed: 19327743